TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
129.61
-10.46 (-7.47%)
At close: Mar 6, 2026, 4:00 PM EST
129.61
0.00 (0.00%)
After-hours: Mar 6, 2026, 7:12 PM EST
TransMedics Group Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for TransMedics Group stock have an average target of 152.33, with a low estimate of 115 and a high estimate of 175. The average target predicts an increase of 17.53% from the current stock price of 129.61.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TransMedics Group stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $114 → $149 | Hold | Maintains | $114 → $149 | +14.96% | Feb 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $150 → $175 | Buy | Maintains | $150 → $175 | +35.02% | Feb 25, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $140 → $160 | Buy | Maintains | $140 → $160 | +23.45% | Feb 25, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $155 → $170 | Buy | Maintains | $155 → $170 | +31.16% | Feb 25, 2026 |
| Needham | Needham | Strong Buy Maintains $166 → $174 | Strong Buy | Maintains | $166 → $174 | +34.25% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
751.53M
from 605.49M
Increased by 24.12%
Revenue Next Year
891.99M
from 751.53M
Increased by 18.69%
EPS This Year
2.61
from 4.87
Decreased by -46.35%
EPS Next Year
3.76
from 2.61
Increased by 43.80%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 786.1M | 966.0M | ||
| Avg | 751.5M | 892.0M | ||
| Low | 707.6M | 817.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 29.8% | 28.5% | ||
| Avg | 24.1% | 18.7% | ||
| Low | 16.9% | 8.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.30 | 4.40 | ||
| Avg | 2.61 | 3.76 | ||
| Low | 1.71 | 2.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -32.3% | 68.3% | ||
| Avg | -46.4% | 43.8% | ||
| Low | -65.0% | -6.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.